Literature DB >> 27432092

Serum Lipid Levels in Patients with Eating Disorders.

Yoshikatsu Nakai1, Shun'ichi Noma, Mitsuo Fukusima, Ataru Taniguchi, Satoshi Teramukai.   

Abstract

Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432092     DOI: 10.2169/internalmedicine.55.5632

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Autonomic nervous system function in women with anorexia nervosa.

Authors:  Zoe M Jenkins; David J Castle; Nina Eikelis; Andrea Phillipou; Gavin W Lambert; Elisabeth A Lambert
Journal:  Clin Auton Res       Date:  2021-11-11       Impact factor: 4.435

2.  Metabolomics signatures of acutely ill and short-term weight recovered women with anorexia nervosa.

Authors:  Palmiero Monteleone; Alessio Maria Monteleone; Jacopo Troisi; Riccardo Dalle Grave; Giulio Corrivetti; Simona Calugi; Giovanni Scala; Giuseppina Patriciello; Adalgisa Zanetti; Mario Maj
Journal:  Mol Psychiatry       Date:  2019-11-07       Impact factor: 15.992

3.  Managing Risk of Non-Communicable Diseases in Women with Bulimia Nervosa or Binge Eating Disorders: A Randomized Trial with 12 Months Follow-Up.

Authors:  Therese Fostervold Mathisen; Jorunn Sundgot-Borgen; Jan H Rosenvinge; Solfrid Bratland-Sanda
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

4.  Long-Term Outcomes from a 10-Year Follow-Up of Women Living with a Restrictive Eating Disorder: A Brief Report.

Authors:  Enza Speranza; Lidia Santarpia; Maurizio Marra; Emilia De Filippo; Olivia Di Vincenzo; Delia Morlino; Fabrizio Pasanisi; Franco Contaldo
Journal:  Nutrients       Date:  2020-08-04       Impact factor: 5.717

5.  Relationship between anxiety, depressive symptoms and compulsive overeating disorder in patients with cardiovascular diseases.

Authors:  Géssica Damares Garcia; Daniele Alcalá Pompeo; Letícia Palota Eid; Cláudia Bernardi Cesarino; Maria Helena Pinto; Laryssa Wilson Paiva Gonçalves
Journal:  Rev Lat Am Enfermagem       Date:  2018-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.